Compare BCAB & REE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BCAB | REE |
|---|---|---|
| Founded | 2007 | 2011 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Auto Manufacturing |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 20.8M | 21.7M |
| IPO Year | 2020 | N/A |
| Metric | BCAB | REE |
|---|---|---|
| Price | $0.19 | $0.59 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 3 | 2 |
| Target Price | $1.00 | ★ $11.75 |
| AVG Volume (30 Days) | ★ 3.1M | 113.4K |
| Earning Date | 11-13-2025 | 03-16-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $207,000.00 |
| Revenue This Year | N/A | $327.73 |
| Revenue Next Year | N/A | $36,888.82 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.14 | $0.53 |
| 52 Week High | $1.43 | $8.66 |
| Indicator | BCAB | REE |
|---|---|---|
| Relative Strength Index (RSI) | 27.25 | 28.33 |
| Support Level | $0.14 | $0.58 |
| Resistance Level | $0.39 | $0.64 |
| Average True Range (ATR) | 0.05 | 0.06 |
| MACD | 0.00 | -0.01 |
| Stochastic Oscillator | 22.20 | 3.41 |
BioAtla Inc is a clinical-stage biopharmaceutical company. The company is engaged in the development of a novel class of specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its pipeline products comprise mecbotamab vedotin (BA3011), ozuriftamab vedotin (BA3021), and evalstotug (BA3071), and its Phase 1 clinical trial of BA3182 (CAB-EpCAM x CAB-CD3) and Bispecific antibody programs.
REE Automotive Ltd is an automotive technology company focused on building commercial electric vehicles controlled fully by-wire. The company is in early stages of commercialization and develop and produce software-defined vehicle (SDV) technology that manages vehicle operations and features through proprietarily-developed software. The company has geographical preference in Israel, Germany, United States, United Kingdom, and other regions.